Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7N2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,494
Award facts
- Contract value 100% obligated
- $8,494.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $8,494.42 delivery order by the Defense Logistics Agency on January 9, 2026, for REPATHA 140 mg/ml SureClick auto-injectors. The contract utilizes firm fixed-price pricing with no set-aside designation, reflecting a competitively awarded delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by January 12, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order falls under AmerisourceBergen's larger $999,999,999 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an expanded indefinite delivery contract valued up to $999,999,999 with DLA through December 2031. REPATHA is a prescription medication used for cholesterol management in patients with cardiovascular disease, demonstrating the company's role in supplying critical specialty medications across multiple therapeutic domains to support military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV7N2?
SPE2DR26FV7N2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FV7N2 worth?
The government has obligated $8,494 on SPE2DR26FV7N2.
Is contract SPE2DR26FV7N2 an order under another contract?
Yes. SPE2DR26FV7N2 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7N2 competed?
The extent of competition for SPE2DR26FV7N2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award